Trial Profile
A Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study of the Effect of ERB-041 in the Reduction of Symptoms Associated With Endometriosis in Reproductive-Age Women.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jul 2010
Price :
$35
*
At a glance
- Drugs Prinaberel (Primary)
- Indications Endometriosis
- Focus Therapeutic Use
- 07 Dec 2007 Status changed from in progress to completed.
- 03 Oct 2005 New trial record.